Modulation of autoimmunity and atherosclerosis - common targets and promising translational approaches against...

Area of Science:

• Cardiovascular Science
• Immunology
• Inflammation Biology

Background:

• Atherosclerosis is a chronic inflammatory arterial disease linked to risk factors like hyperlipidemia and hypertension.
• Autoimmune diseases significantly elevate the risk of cardiovascular disease (CVD).
• Similarities exist between atherosclerotic CVD and autoimmune conditions, suggesting shared therapeutic targets.

Purpose of the Study:

• To review experimental and clinical studies on immunomodulatory approaches for autoimmune diseases.
• To examine the potential of these immunomodulatory strategies in preventing and treating atherosclerotic CVD.

Main Methods:

• Review of existing clinical and experimental data.
• Analysis of immunomodulatory therapies including immunosuppressants, anticytokine therapy, T and B cell targeting, and vaccination.

Main Results:

• Substantial evidence supports the use of immunomodulatory strategies for both autoimmune diseases and cardiovascular diseases.
• Therapies targeting immune responses show potential for mitigating autoimmune reactions.
• These approaches may be applicable to the prevention and treatment of atherosclerotic CVD.

Conclusions:

• Immunomodulatory therapies represent a promising avenue for managing atherosclerotic cardiovascular disease.
• Targeting immune pathways offers a potential strategy to combat chronic inflammatory conditions like atherosclerosis.
• Further research into these approaches could lead to novel treatments for cardiovascular disease.